Literature DB >> 1867115

Automated direct assay system for RU38486, an antiprogesterone-antiglucocorticoid agent, and its metabolites using high performance liquid chromatography.

K Nagoshi1, N Hayashi, K Sekiba.   

Abstract

An automated direct assay system using high performance liquid chromatography was developed for the measurement of RU38486 and its three metabolites (RU42698, RU42848, RU42633) in human serum. Serum concentrations of these compounds were measured up to 144 h following single oral administration of 200 (200 mg group, n = 3) or 400 mg (400 mg group, n = 3) of RU38486 to healthy female volunteers. The serum half-lives (200 mg group-400 mg group) of RU38486, RU42698, RU42848 and RU42633 were 31.8-33.1 h, 41.2-39.3 h, 33.9-36.6 h and 29.2-36.6 h, respectively. Our system could quantify them easily and simultaneously, and was considered to be valuable in studies on the relationship between the pharmacokinetics and the clinical effects of RU38486.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1867115     DOI: 10.18926/AMO/32187

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  3 in total

Review 1.  Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

Authors:  R N Brogden; K L Goa; D Faulds
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 2.  Antiprogestin pharmacodynamics, pharmacokinetics, and metabolism: implications for their long-term use.

Authors:  G R Jang; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1997-12

3.  Quantitative analysis of RU38486 (mifepristone) by HPLC triple quadrupole mass spectrometry.

Authors:  Natalie Z M Homer; Rebecca M Reynolds; Cecilia Mattsson; Matthew A Bailey; Brian R Walker; Ruth Andrew
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-12-27       Impact factor: 3.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.